M

MITech Co Ltd
KOSDAQ:179290

Watchlist Manager
MITech Co Ltd
KOSDAQ:179290
Watchlist
Price: 6 850 KRW Market Closed
Market Cap: 221.7B KRW

Net Margin

30.1%
Current
Declining
by 0.7%
vs 3-y average of 30.9%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
30.1%
=
Net Income
₩18.8B
/
Revenue
₩62.2B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
30.1%
=
Net Income
₩18.8B
/
Revenue
₩62.2B

Peer Comparison

Country Company Market Cap Net
Margin
KR
MITech Co Ltd
KOSDAQ:179290
221.7B KRW
Loading...
US
Abbott Laboratories
NYSE:ABT
211.7B USD
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
191.8B USD
Loading...
US
Stryker Corp
NYSE:SYK
139.1B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
130.5B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
124B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
59.1B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
49.5B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
57.2B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
49B USD
Loading...
US
Resmed Inc
NYSE:RMD
37.6B USD
Loading...
No Stocks Found

Market Distribution

Higher than 96% of companies in Korea
Percentile
96th
Based on 2 632 companies
96th percentile
30.1%
Low
-168 471.3% — -2.9%
Typical Range
-2.9% — 5.8%
High
5.8% — 21 012.5%
Distribution Statistics
Korea
Min -168 471.3%
30th Percentile -2.9%
Median 1.9%
70th Percentile 5.8%
Max 21 012.5%

MITech Co Ltd
Glance View

Market Cap
221.7B KRW
Industry
Health Care

M.I.Tech Co., Ltd. develops and manufactures non-vascular stent system. The company is headquartered in Pyeongtaek, Gyeonggi-Do and currently employs 157 full-time employees. The company went IPO on 2018-11-29. is a Korea-based company mainly engaged in the manufacturing and sale of stents. Stents include biliary, esophagus, pyloric, large intestine, duodenal stents, and stents for sample and study, among others. The Company’s stents are sold under the brand names of CHOOSTENT and HANAROSTENT. In addition, the Company is engaged in the manufacture and sale of low frequency therapies, crushers and blood glucose meters. The firm distributes its products within the domestic market and to overseas markets.

Intrinsic Value
13 744.46 KRW
Undervaluation 50%
Intrinsic Value
Price
M
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
30.1%
=
Net Income
₩18.8B
/
Revenue
₩62.2B
What is MITech Co Ltd's current Net Margin?

The current Net Margin for MITech Co Ltd is 30.1%, which is below its 3-year median of 30.9%.

How has Net Margin changed over time?

Over the last 3 years, MITech Co Ltd’s Net Margin has decreased from 32.7% to 30.1%. During this period, it reached a low of 23.8% on Sep 30, 2023 and a high of 34.6% on Sep 30, 2024.

Back to Top